Company Filing History:

14 out of 377

Aventis Pharma S.a.

patents

8 out of 247

Rhone-poulenc Rorer S.a.

Years Active: 1983-2007

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7232799 - Streptogramin derivatives and compositions thereof (2007-06-19),

2. 7166594 - Streptogramin derivatives, their preparation and compositions containing them (2007-01-23),

3. 7019110 - Streptogramin derivatives, preparation method and compositions containing same (2006-03-28),

4. 6962901 - Streptogramin derivatives, their preparation and compositions which contain them (2005-11-08),

5. 6958383 - Streptogramin derivatives, preparation method and compositions containing same (2005-10-25),

6. 6833382 - Streptogramins and method for preparing same by mutasynthesis (2004-12-21),

7. 6815437 - Streptogramines, their preparation and compositions containing them (2004-11-09),

8. 6699897 - Streptogramin derivatives, their preparation and compositions which contain them (2004-03-02),

9. 6596717 - Streptogramin derivatives, their preparation and compositions which contain them (2003-07-22),

10. 6569854 - Streptogramin derivatives, their preparation and compositions containing them (2003-05-27),

11. 6562852 - Streptogramin derivatives, their preparation and compositions which contain them (2003-05-13),

12. 6541451 - Streptogramin derivatives, their preparation and compositions containing them (2003-04-01),

13. 6384014 - Purified form of streptogramines, preparation of same and pharmaceutical compositions containing them (2002-05-07),

14. 6352839 - Streptogramins for preparing same by mutasynthesis (2002-03-05),

15. 5994299 - Cyclosporin compounds, their preparation and the pharmaceutical (1999-11-30),

Title: Jean-Claude Barriere: A Visionary in Pharmaceutical Innovations

Introduction

Jean-Claude Barriere is a prominent inventor based in Bures sur Yvette, France. With an impressive portfolio of 28 patents, his contributions to the pharmaceutical field, particularly in the realm of streptogramin derivatives, stand out as significant advancements in drug composition and formulation.

Latest Patents

Among his most recent patents, Barriere has made noteworthy claims regarding "Streptogramin derivatives and compositions thereof." This invention outlines pharmaceutical compositions that feature Group A streptogramin derivatives of a specified formula and salts, combined with at least one natural Group B streptogramin derivative. Another patent focuses on the "Streptogramin derivatives, their preparation and compositions containing them," revealing the general formula for Group A streptogramin derivatives. His work showcases innovations that could lead to enhanced therapeutic options in the pharmaceutical industry.

Career Highlights

Jean-Claude Barriere has had a distinguished career with notable companies in the pharmaceutical sector. He has worked at Aventis Pharma S.A. and Rhone-Poulenc Rorer S.A., where he has been instrumental in research and development, leading to impactful innovations in drug formulation.

Collaborations

Throughout his career, Barriere has collaborated with talented professionals in his field, including Eric Bacque and Jean-Marc Paris. These partnerships have aided in the advancement of his research and the successful realization of his patents.

Conclusion

Jean-Claude Barriere's contributions to pharmaceutical innovations, particularly through his extensive patent portfolio, reflect a dedication to advancing medical science. His work on streptogramin derivatives holds promise for future pharmacological applications, reinforcing the importance of collaboration and innovation in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com